The Impact of Obesity on Performing Lymphadenectomy and Its Outcome in Ovarian Cancer Patients
- 1 Oncology Center Mansoura University, Mansoura, Egypt
- 2 Oncology Center Mansoura University, Mansoura, Egypt
- 3 Mansoura University Hospitals, Mansoura, Egypt
- 4 Oncology Center Mansoura University, Mansoura, Egypt
- 5 Mansoura University Hospitals, Mansoura, Egypt
- 6 Oncology Center Mansoura University, Mansoura, Egypt
- 7 Oncology Center Mansoura University, Mansoura, Egypt
- 8 Oldenburg University, Oldenburg, Germany
- 9 Oncology Center Mansoura University, Mansoura, Egypt
- 10 Mansoura University Hospitals, Mansoura, Egypt
- 11 Tanta Cancer Center, Tanta, Egypt
- 12 Oncology Center Mansoura University, Mansoura, Egypt
Abstract
Background: This study discusses the effect of obesity on the number of lymph nodes harvested during systematic LND and the LND-related complications in ovarian cancer patients. Methods: This retrospective study enrolled women with ovarian cancer who were consecutively subjected to open surgical resection that included systematic LND (pelvic and para-aortic) in the Oncology Center in Mansoura University (OCMU) during the period between January 2012 and June 2017. Patients were categorized according to the recommendations of World Health Organization by their BMI as non-obese (BMI < 30.0 kg/m 2 ) and obese (BMI ≥ 30.0 kg/m 2 ). Results: Seventy-seven women with ovarian cancer were enrolled in the study according to our inclusion and exclusion criteria. 43 females (55.8%) were grouped as obese and 34 (44.2%) as non-obese. Lymph nodes retrieved in total and in different stations separately (pelvic and para-aortic) were all similar among patients in both groups. LND-related intraoperative complications were observed in 8 patients (18.6%) in the obese group and 3 patients in the non-obese group (8.8%) (P = 0.347). Hospital stay was the same in the two groups with a median of 4 days (IQR 3 - 5). Postoperative complications occurred in 13 patients (30.2%) in the obese group and only in one patient (3%) in the non-obese group (P = 0.004). Conclusion: Obese ovarian cancer patients may safely undergo comprehensive staging involving extensive lymph node dissection in open surgeries without significant increase in the rates of intraoperative complications. Whereas, postoperative complications (wound infection and thromboembolic events) tend to occur at higher rates with obese patients. Trial registration: This study was retrospectively registered and approved at faculty of Medicine Mansoura University, Egypt with IRB approval number R.18.02.46 .
- Mikami, M. (2014) Role of Lymphadenectomy for Ovarian Cancer. Journal of Gynecologic Oncology, 25, 279-281. https://doi.org/10.3802/jgo.2014.25.4.279
- Gao, J., Yang, X. and Zhang, Y. (2015) Systematic Lymphadenectomy in the Treatment of Epithelial Ovarian Cancer: A Meta-Analysis of Multiple Epidemiology Studies. Japanese Journal of Clinical Oncology, 45, 49-60. https://doi.org/10.1093/jjco/hyu175
- O’Hanlan, K.A., Sten, M.S., O’Holleran, M.S., Ford, N.N., Struck, D.M. and McCutcheon, S.P. (2015) Infrarenal Lymphadenectomy for Gynecological Malignancies: Two Laparoscopic Approaches. Gynecologic Oncology, 139, 330-337. https://doi.org/10.1016/j.ygyno.2015.09.019
- Papadia, A., Ragni, N. and Salom, E.M. (2006) The Impact of Obesity on Surgical Outcomes: A Review. International Journal of Gynecological Cancer, 26, 944-952. https://doi.org/10.1111/j.1525-1438.2006.00577.x
- Chan, J.K., et al. (2007) The Potential Therapeutic Role of Lymph Node Resection in epithelial Ovarian Cancer: A Study of 13,918 Patients. British Journal of Cancer, 96, 1817-1822. https://doi.org/10.1038/sj.bjc.6603803
- Kumar, A., Bakkum-Gamez, J.N., Weaver, A.L., McGree, M.E. and Cliby, W.A. (2014) Impact of Obesity on Surgical and Oncologic Outcomes in Ovarian Cancer. Gynecologic Oncology, 135, 19-24. https://doi.org/10.1016/j.ygyno.2014.07.103
- Zhou, J., Shan, G. and Chen, Y. (2016) The Effect of Lymphadenectomy on Survival and Recurrence in Patients with Ovarian Cancer: A Systematic Review and Meta-Analysis. Japanese Journal of Clinical Oncology, 46, 718-726. https://doi.org/10.1093/jjco/hyw068
- Harter, P., et al. (2017) LION: Lymphadenectomy in Ovarian Neoplasms—A Prospective Randomized AGO Study Group Led Gynecologic Cancer Intergroup Trial. Journal of Clinical Oncology, 35, 5500.
- Calle, E.E. and Kaaks, R. (2004) Overweight, Obesity and Cancer: Epidemiological Evidence and Proposed Mechanisms. Nature Reviews Cancer, 4, 579-591. https://doi.org/10.1038/nrc1408
- Upadhyay, J., Farr, O., Perakakis, N., Ghaly, W. and Mantzoros, C. (2018) Obesity as a Disease. Medical Clinics of North America, 102, 13-33. https://doi.org/10.1016/j.mcna.2017.08.004
- Aletti, G.D., Dowdy, S., Podratz, K.C. and Cliby, W.A. (2006) Role of Lymphadenectomy in the Management of Grossly Apparent Advanced Stage Epithelial Ovarian Cancer. American Journal of Obstetrics & Gynecology, 195, 1862-1868. https://doi.org/10.1016/j.ajog.2006.06.068